If You Invested $1000 In This Stock 10 Years Ago, You Would Have $7,900 Today

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 10 years by 12.09% on an annualized basis…

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 10 years by 12.09% on an annualized basis producing an average annual return of 23.11%. Currently, Vertex Pharmaceuticals has a market capitalization of $81.16 billion.

Buying $1000 In VRTX: If an investor had bought $1000 of VRTX stock 10 years ago, it would be worth $7,907.95 today based on a price of $316.16 for VRTX at the time of writing.

Vertex Pharmaceuticals’s Performance Over Last 10 Years

comp_fig

Finally — what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Bank7: Q2 Earnings Insights

  Bank7 (NASDAQ:BSVN) reported its Q2 earnings results on Wednesday, July 27, 2022 at 09:00 AM. Here's what investors need to know about the announcement. Earnings Bank7 reported in-line EPS of $0.76 versus an estimate of $0.76.

BSVN

Read More

2U’s Earnings: A Preview

2U (NASDAQ:TWOU) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that 2U will report an earnings per share (EPS) of $-0.26.

TWOU